Geovax Labs Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2024 * | - | Sales 2025 * | 24.3M 33.14M | Capitalization | 7.33M 10M |
---|---|---|---|---|---|
Net income 2024 * | -31M -42.27M | Net income 2025 * | -25M -34.09M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.3 x |
P/E ratio 2024 * |
-0.33
x | P/E ratio 2025 * |
-1.65
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.56% |
Latest transcript on Geovax Labs Inc
Managers | Title | Age | Since |
---|---|---|---|
David Dodd
CEO | Chief Executive Officer | 74 | 10-03-16 |
Mark Reynolds
DFI | Director of Finance/CFO | 62 | 06-09-30 |
Erica Raiden
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert McNally
BRD | Director/Board Member | 76 | 06-11-30 |
Randal Chase
BRD | Director/Board Member | 74 | 15-03-18 |
John Spencer
BRD | Director/Board Member | 83 | 06-09-27 |
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.44B | |
-10.62% | 37.68B | |
+40.49% | 39.84B | |
+29.92% | 31.46B | |
-9.78% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |